ECG
Interim CEO Ira Bahr said that his company is undeterred by Apple's entrance into the mobile ECG market.
The collaboration will investigate heart health outcomes and medication adherence among seniors, and is scheduled to begin in 2019.
At WISH in Doha Qatar last month, Glazkova was a featured young entrepreneur for her Sense2beat technology.
The investigation compared tests from 204 STEMI patients presenting in five different settings.
This is the first FDA clearance for Apple and pushes the Watch further into healthcare than ever before.
Personal MedSystems, a German medical device company better known by its brand name CardioSecur, has raised $5.
San Francisco-based AliveCor, which offers smartphone-enabled ECG devices, has announced former Google SVP Vic Gundotra as its new CEO.
Belfast, Northern Ireland-based Intelesens has received FDA 510(k) clearance for its wearable vital signs monitor, called zensor, designed for monitoring patients outside the hospital.
The ACT device paired with a previous phone.
It's been almost a year since AliveCor began offering its first FDA-cleared algorithm, its atrial fibrillation detection algorithm, to customers.